Twenty strains of Colorado tick fever (CTF) virus, isolated from ticks, mammals and humans, and two antigenic relatives of CTF virus were compared in crossneutralization tests. Viruses were tested using single-inoculation sera prepared in hamsters. Antigenic variation, as measured by differences detected in the neutralization test, was noted among the virus isolates identified as strains of CTF virus. The virus strains isolated from humans appeared to vary the most in serological reactions. The two antigenic relatives of CTF virus are clearly distinct from strains of CTF and are different from each other. Antigenic relationships between these two viruses were established using two sets of single-inoculation antisera and both complement fixation and neutralization tests. Six distinct antigenic variants of CTF virus isolated from humans and the virus strain from ticks (75V1906) that showed the least antigenic variation, were tested against 49 coded serum pairs from clinically diagnosed cases of CTF. Significant differences were noted in the number of convalescent-phase sera that reacted with each virus strain and in the number of seroconversions observed with each test virus strain. Convalescent phase sera that reacted with multiple virus strains often varied significantly in antibody titre from one virus strain to another. This indicates that, in some instances, antibody was probably produced in response to infection by different antigenic variants of CTF virus.
Twenty strains of Colorado tick fever (CTF) virus, isolated from ticks, mammals and humans, and two antigenic relatives of CTF virus were compared in crossneutralization tests. Viruses were tested using single-inoculation sera prepared in hamsters. Antigenic variation, as measured by differences detected in the neutralization test, was noted among the virus isolates identified as strains of CTF virus. The virus strains isolated from humans appeared to vary the most in serological reactions. The two antigenic relatives of CTF virus are clearly distinct from strains of CTF and are different from each other. Antigenic relationships between these two viruses were established using two sets of single-inoculation antisera and both complement fixation and neutralization tests. Six distinct antigenic variants of CTF virus isolated from humans and the virus strain from ticks (75V1906) that showed the least antigenic variation, were tested against 49 coded serum pairs from clinically diagnosed cases of CTF. Significant differences were noted in the number of convalescent-phase sera that reacted with each virus strain and in the number of seroconversions observed with each test virus strain. Convalescent phase sera that reacted with multiple virus strains often varied significantly in antibody titre from one virus strain to another. This indicates that, in some instances, antibody was probably produced in response to infection by different antigenic variants of CTF virus.
Colorado tick fever (CTF) virus is a member of the Orbivirus genus, although it has been suggested that taxonomic placement should be reevaluated (Gorman et al., 1983) . All the other orbiviruses have 10 dsRNA genome segments (Gorman et al., 1983) whereas CTF virus has 12 (Knudson, 1981) .
In the United States, CTF virus is limited to 11 western states (Lane et al., 1982) , but CTF is the most commonly reported arbovirus disease of humans in this country (Main, 1977) . In nature, the virus is maintained in a cycle involving larval and nymphal stages of Dermacentor andersoni ticks and a variety of rodent species and is ultimately transmitted to humans by adult D. andersoni (Poland, 1985) . The distribution of CTF virus coincides with the range of the principal vector, D. andersoni (Emmons, 1981) . Isolates of CTF virus are easily obtained during the late spring and early summer from infected ticks, mammals and humans (Bowen et al., 1981b; Emmons, 1981; Poland, 1985) . To our knowledge, no one has studied the antigenic stability of virion surface structures that are involved in the infection process or that participate in the neutralization reaction.
Our objective was to investigate antigenic variation between isolates of CTF virus obtained over a period of years from ticks, small mammals and humans infected in a limited geographical area. * SM4 = suckling mouse passage 4; V 1 = Vero cell culture passage 1 ; P-35 = animal passages Average survival time of suckling mice inoculated with approximately 100 LD50. :~ dex p.f.u./ml. § dex LDso/ml.
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Virus sources, dates and locales of isolation and passage histories are given in Table 1 . Working stocks of all viruses were clarified 10~o suspensions of infected suckling mouse brains in phosphate-buffered saline pH 7.2, containing 4.0% bovine albumin.
Approximately equal numbers of virus isolates from small mammals, ticks and humans were assembled for study (Table 1) . Except for three, all viruses were isolated from sources collected in Colorado, U.S.A. Eyach virus was included because it is an antigenic relative of, but distinct from, the prototype CTF virus (Elorio strain) (Rehse-Kupper et al., 1976) . Strains $6-14-03 and R-19372 were chosen because the former was isolated from a source collected in an area outside the known distribution of D. andersoni ticks (Lane et al., 1982) , whereas strain R-19372 represented an isolate originating from a different ecosystem. With the exception of Eyach virus and the Florio strain of CTF virus, all viruses had relatively low passage levels (three to six total passages).
Vero, LLC-MK2 and CER cell cultures were grown and maintained by standard methods. The Vero and LLC-MK2 cell cultures were grown in medium 199 (M-199) containing 10% foetal calf serum, while CER cells were grown in MEM with 10% foetal calf serum. Serum was heatinactivated (56 °C, 30 min) before use.
For each virus used, four to six adult (3 to 9 months old) hamsters were inoculated once subcutaneously with a virus suspension containing about 6.0 dex (106; Haldane, 1960) suckling mouse LD50. Blood was withdrawn 21 days later, and serum was separated from the clot. Singleinoculation hamster antisera were used because they usually react more specifically in serological tests and because they closely approximate infection-immune sera taken from hosts infected in nature.
One-to two-day-old Swiss albino suckling mice (SM) were inoculated intracerebrally with tenfold virus dilutions. Eight SM were inoculated per dilution and LDs0 endpoints were calculated by the method of Reed & Muench (1938) . Average survival time (AST) was determined for the group of SM inoculated with approximately 100 LDso.
Veto, LLC-MK2 and CER cell cultures were used for viral plaque assays. Cell cultures were grown in six-well plates in a 5~ CO2 incubator. Serial tenfold virus dilutions were inoculated in 0.1 ml volumes into cell cultures and adsorbed for 1 h at 37 °C. Cultures were overlaid with 3.0 ml M-199 or MEM containing Earle's balanced salts solution, 1~ Noble agar, 1~o heatinactivated foetal bovine serum, 2.2 g/1 NaHCO3 and 0.3 g/1 diethylaminoethyl dextran. A second nutrient agar overlay, containing neutral red (final dilution 1:25000), was applied 4 or 6 days later, depending on the virus tested and the cell culture used. Plaques were counted either on the same day, 24 to 48 h later, or 48 to 72 h later.
Complement fixation (CF) tests (Casey, 1965) were also used to detect antigenic differences between virus isolates.
Plaque-reduction neutralization tests (PRNT) used constant virus concentrations and varying serum dilutions (Karabatsos, 1975) ; 50~ titres were calculated by the K/irber method (1931). A final virus plaque count of about 100 p.f.u, was used as the control. Tests were run in duplicate and geometric mean titres were calculated when multiple independent neutralization tests were conducted with the same virus-serum combination. Titre differences of fourfold or greater were considered significant. We did neutralization tests with 24 homologous and heterologous virusserum pairs in replicate. For these, we assessed the statistical significance of differences using Student's t-test. Of these 24, 17 were statistically significant (P < 0.05), and the remaining seven were not. Of those that were not significant, the -fold differences were based on only two replicate determinations, and actual -fold differences ranged from 3.6-to 5.7-fold.
Forty-nine acute and convalescent phase coded human sera from clinically diagnosed cases of CFT were heat-inactivated and tested by PRNT. Labile serum factor was deliberately excluded because of the possibility that its presence would decrease serological specificity (Karabatsos, 1969) . Titres were calculated by determining the reciprocal of the serum dilution that reduced the plaque count by 90~ or more.
All convalescent phase sera were screened in a single test at a final dilution of 1 : 10 against about 100 p.f.u, for each of seven selected isolates of CTF virus (71Vll, R-6225, R-11515, Florio, R-19420, R-19372 and 75V1906) , including the two virus strains that had been used in the initial testing. Positive convalescent phase sera were then titrated against virus isolates that reacted with the convalescent phase sera in the screening test. In addition, the acute serum for the corresponding positive convalescent phase serum was tested at 1:10 or 1:20 dilutions to determine whether antibody was in the acute specimen. Following titration of the positive convalescent phase sera, the number of seroconversions obtained with each virus strain was determined. Seroconversion was considered to have occurred when the titre of the acute phase serum was < 10 and the titre of the convalescent phase serum was at least 20. Additionally, laboratory-prepared hamster antiserum was titrated in a homologous neutralization test for each virus isolate used.
In the initial studies, acute and convalescent phase sera were tested using a 90%0 PRNT with either strain 71V11 or the Florio strain of CTF virus, and labile serum factor was included in some tests to enhance neutralization (Chappell et al., 1971) . At the time, these two virus strains were considered identical. The sera were collected in the years 1977, 1979, 1980 and 1981 and were from patients who acquired their infection in the state of Colorado or several other states of the western United States. Twenty-five suspected cases of CTF were confirmed both by serology and by virus isolation, and an additional 11 cases were confirmed by serology only.
With two exceptions, results of infectivity titrations in Vero cell cultures (Table 1) were comparable to those in CER and LLC-MK2 cell cultures. Neither Eyach virus nor strain $6-14-03 produced plaques in CER or LLC-MK2 cell cultures; however, both viruses produced plaques in Veto cell cultures, although these plaques appeared later than those formed by CTF virus isolates. Plaques of CTF virus isolates were visible on day 4 or 5, but plaques for Eyach virus and strain $6-14-03 were not visible before day 6 or 7. Except for strain $6-14-03, SM provided a more sensitive measure of virus infectivity than did cell cultures. Lethality titres determined in SM ranged from 0.4 to 2.4 dex higher than plaque titres (Table 1 ). The ASTs of SM inoculated with these viruses were all about the same (Table 1) . However, SM inoculated with strains $6-14-03 and 78V1843 survived about 3 days longer than most, while those inoculated with the Florio strain died at least 2 days earlier than most. The Florio strain was the only one of 22 tested that killed weaned mice (3 to 4 weeks old) when inoculated intracerebrally (data not shown). The neutralization test showed some antigenic variability (Table 2) . First, with few exceptions, Eyach virus and strain $6-14-03 showed similar patterns of serological reactivity. Both differed in both directions in their reactions with CTF virus isolates. One-way differences occurred only with virus strains 71V11, 75V1843 and R-19420. Strain $6-14-03 showed a oneway difference with strain 75V3863. In addition, Eyach and $6-14-03 differed from each other in one direction; only antibody to Eyach distinguished the two viruses.
Second, except for their reactions with Eyach and $6-14-03, all CTF virus isolates from ticks and mammals showed less antigenic variation when compared among themselves than when compared with virus isolates from humans. Finally, CTF virus isolates from humans varied significantly in antigenic character when compared among themselves or with CTF virus isolates from other sources. This variation was predominantly based on one-way differences. Further, human isolates 71V11 and 69V28 were virtually indistinguishable antigenically, as were human isolates R-6225 and R-15823, and R-1575 and R-11515. Each antigenically identical pair differed from each other pair and from other human isolates. Two CTF virus isolates from humans, strains Florio (isolated in 1943) and R-19372 (isolated in 1977) , did not share two-way identity with any of the other viruses or with each other. Initial studies with single-inoculation hamster antiserum indicated that Eyach and $6-14-03 viruses were distinguished from each other only when they were tested against antibody to Eyach virus. Therefore, a second set of single-inoculation immune reagents prepared in mice was employed. When the viruses were cross-tested by CF and PRNT, >1 fourfold differences were shown in both directions (data not shown). Thus, these viruses are distinct from each other and from the prototype CTF (Florio) virus. The antigenic relationships between strain $6-14-03, Eyach, and CTF viruses were also confirmed independently by one of us (R.W.E.) using neutralization tests.
If any of these isolates are true antigenic variants, they would differ in reactivity when tested with sera from humans with serologically confirmed CTF virus infection. Thirty-six of 49 coded acute and convalescent phase human sera used for this testing previously had been shown to increase >~ fourfold in PRNT antibody between acute and convalescent phase serum samples when tested with either the Florio or the 71V11 strain of CTF virus.
The number of convalescent phase sera that reacted positively depended on the antigenic variant against which they were tested (Table 3) . Strains R-11515 and Florio reacted with more convalescent phase sera than did any other strain, whereas R-19372 reacted with the fewest. Strain 75V1906 reacted with the second fewest convalescent phase sera and was one of two strains (with 76-1-1078) that showed the least antigenic variation in cross-neutralization tests.
Convalescent phase -era with neutralizing antibody were titrated against each virus variant with which they had reacted previously. Antibody was not detected in any of the acute sera. The number of paired samples that demonstrated seroconversion varied considerably, depending on the virus strain against which they were tested (Table 3) . As was expected, the two strains that reacted with the greatest number of convalescent phase sera in the screening neutralization test (R-11515, Florio) also demonstrated the greatest number of seroconversions, but neither virus strain detected all of the patients that were serologically positive in the initial diagnostic tests. Nevertheless, i> fourfold changes in titre were demonstrated in paired serum samples from 31 persons, as shown by tests with more than one strain of CTF virus; one serum pair could not be tested because insufficient serum remained after the screening neutralization test. Antibody titres varied significantly. For example, neutralization titres of one convalescent phase serum ranged from < 10 to ~>2560 depending on the virus used; for other sera titres ranged from < 10 to 20, 40 to 320, 80 to 1280, 40 to 1280, <10 to 320, and 80 to ~>2560.
Antigenic variation was observed among CTF virus isolates compared by the neutralization test. To our knowledge, this is the first reported description of antigenic variation among strains of CTF virus. We do not believe that passage in laboratory mice alone would result in the antigenic alterations observed. The Florio strain had undergone nearly 100 passages in laboratory animals yet showed the same pattern of antigenic variation as did strain R-19372, which had been passed four times in mice. However, the shorter AST of SM inoculated with the Florio strain is probably a reflection of its high mouse passage history.
In some respects, antigenic variation observed among strains of CTF virus appears to result from a process analogous to the 'antigenic drift' of influenza virus (Murphy & Webster, 1985) . The antigenic variation observed in our study was manifested as one-way differences among strains of CTF virus, although several strains exhibited two-way differences. CTF virus induces viraemias of long duration in human infections, in naturally infected lower animals, and in animals infected experimentally (Bowen et al., 1981a, b; Burgdorfer, 1959; Emmons, 1966; Emmons et al., 1972; Hughes et al., 1974) . In addition, CTF virus has been isolated during the viraemic stage in which homologous antibody is present (Emmons et al., 1972; Hughes et al., 1974) . It may be that antibody provides selective pressure in enhancing the replication of variants arising during infection of a host. Although antigens of CTF virus strains from humans appear to vary the most, most of these antigenic changes probably occurred prior to human infection. We do not believe that the mutation rate for CTF virus is high enough for antigenic variants to arise and be selected during a 'single replication cycle' (during infection of a human host). There is frequent opportunity for change during passage of the virus between a vector and a small mammal host. Antigenic modification here may be a gradual process in which some strains are relatively unaltered antigenically, others are considerably altered, and isolates from humans represent the end result of such a process.
Additional evidence for antigenic variation is provided by the different serological reactions obtained when human serum pairs were tested for antibody to different isolates of CTF virus. It is possible that the use of labile serum factor in these tests would have allowed any of the CTF virus isolates to detect antibody in all positive convalescent phase sera. Nevertheless, differences in serological reactivity probably reflect differences in antibody response to infection by antigenically different strains of CTF virus. D. W. Trent et al. (personal communication) found that the migration patterns of the undenatured genomic viral RNA of 19 of the 22 isolates of CTF virus used in our study varied markedly in SDS-polyacrylamide gel electrophoresis. Isolates not examined were Eyach virus and strains $6-14-03 and 76-1-l 810. There was no correlation between migrational variation and date, source, or area of isolation, passage history or antigenic variation.
The genetic relatedness of l0 unspecified CTF virus strains was examined by RNA-RNA blot hybridization using strains CTF-FMA or CTF-18 as probes (Bodkin & Knudson, 1987) . The authors concluded that these CTF virus isolates represented a genetically homogeneous group. Segments four or six of certain isolates were less similar to the corresponding segment in CTF-FMA than were other genome segments. However, because this hybridization technique may not detect as much as 26~ base mismatch (Bodkin & Knudson, 1985) , significant genetic variation that cannot be demonstrated by this method may be detected in studies of antigen expression. Furthermore, if antigenic variants of CTF virus resulted from a point mutation or the cumulative effect of two or three point mutations, as has been described for variants of influenza virus (Murphy & Webster, 1985) , the few nucleotide base changes would probably not be recognized by this dot-blot hybridization technique.
Strain $6-14-03, from a hare, Lepus calijbrnicus, collected in northwestern California, is distinct from CTF (Florio) virus and more closely related to Eyach virus isolated in West Germany (Rehse-Kupper et al., 1976) and France (Chastel et al., 1984) . Another virus isolate from California (T5-2092; western grey squirrel, Sciurus griseus) is identical by PRNT to strain $6-14-03 (data not shown). The virus from the squirrel was also isolated in an area of California outside the previously recognized range of CTF virus (Lane et al., 1982) . Thus, strains $6-14-03 and T5-2092 are strains of a virus that is distinct from both CTF and Eyach viruses. Presently, the CTF serogroup consists of three distinct virus types' CTF virus, including a continuum of antigenic variants; Eyach virus; and strain $6-14-03.
